News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,678 Results
Type
Article (33696)
Company Profile (720)
Press Release (633253)
Multimedia
Podcasts (94)
Webinars (19)
Section
Business (197109)
Career Advice (2130)
Deals (36272)
Drug Delivery (120)
Drug Development (77891)
Employer Resources (165)
FDA (15398)
Job Trends (14708)
News (332278)
Policy (28716)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1269)
Academic (1)
Accelerated approval (29)
Adcomms (23)
Allergies (136)
Alliances (46831)
ALS (171)
Alzheimer's disease (1576)
Antibody-drug conjugate (ADC) (309)
Approvals (15620)
Artificial intelligence (510)
Autoimmune disease (155)
Automation (32)
Bankruptcy (376)
Best Places to Work (10834)
BIOSECURE Act (23)
Biosimilars (179)
Biotechnology (444)
Bladder cancer (142)
Brain cancer (52)
Breast cancer (560)
Cancer (4485)
Cardiovascular disease (388)
Career advice (1779)
Career pathing (38)
CAR-T (278)
CDC (20)
Celiac Disease (1)
Cell therapy (745)
Cervical cancer (31)
Clinical research (67091)
Collaboration (1714)
Company closure (4)
Compensation (1141)
Complete response letters (70)
COVID-19 (2281)
CRISPR (87)
C-suite (861)
Cystic fibrosis (144)
Data (5955)
Decentralized trials (2)
Denatured (8)
Depression (137)
Diabetes (458)
Diagnostics (6579)
Digital health (42)
Diversity (6)
Diversity, equity & inclusion (38)
Drug discovery (242)
Drug pricing (192)
Drug shortages (27)
Duchenne muscular dystrophy (221)
Earnings (86457)
Editorial (52)
Employer branding (24)
Employer resources (145)
Events (114205)
Executive appointments (996)
FDA (18376)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (1425)
Gene editing (199)
Generative AI (47)
Gene therapy (587)
GLP-1 (975)
Government (3041)
Grass and pollen (8)
Guidances (373)
Healthcare (15883)
HIV (52)
Huntington's disease (48)
IgA nephropathy (82)
Immunology and inflammation (268)
Immuno-oncology (59)
Indications (99)
Infectious disease (2533)
Inflammatory bowel disease (185)
Inflation Reduction Act (13)
Influenza (108)
Intellectual property (247)
Interviews (429)
IPO (17325)
IRA (50)
Job creations (4224)
Job search strategy (1452)
JPM (59)
Kidney cancer (14)
Labor market (80)
Layoffs (631)
Leadership (34)
Legal (7150)
Liver cancer (89)
Longevity (13)
Lung cancer (591)
Lymphoma (345)
Machine learning (41)
Management (60)
Manufacturing (793)
MASH (164)
Medical device (13871)
Medtech (13925)
Mergers & acquisitions (20009)
Metabolic disorders (1232)
Multiple sclerosis (154)
NASH (19)
Neurodegenerative disease (320)
Neuropsychiatric disorders (97)
Neuroscience (2805)
Neurotech (1)
NextGen: Class of 2026 (5984)
Non-profit (1923)
Now hiring (66)
Obesity (594)
Opinion (291)
Ovarian cancer (148)
Pain (200)
Pancreatic cancer (223)
Parkinson's disease (278)
Partnered (33)
Patents (494)
Patient recruitment (478)
Peanut (57)
People (58189)
Pharmaceutical (134)
Pharmacy benefit managers (27)
Phase 1 (21165)
Phase 2 (29982)
Phase 3 (22137)
Pipeline (5013)
Policy (265)
Postmarket research (1909)
Preclinical (8519)
Press Release (64)
Prostate cancer (230)
Psychedelics (53)
Radiopharmaceuticals (291)
Rare diseases (835)
Real estate (5730)
Recruiting (69)
Regulatory (22657)
Reports (40)
Research institute (1365)
Resumes & cover letters (332)
Rett syndrome (25)
RNA editing (17)
RSV (74)
Schizophrenia (151)
Series A (255)
Series B (195)
Service/supplier (26)
Sickle cell disease (97)
Special edition (25)
Spinal muscular atrophy (155)
Sponsored (29)
Startups (3914)
State (2)
Stomach cancer (17)
Supply chain (101)
Tariffs (96)
The Weekly (85)
Vaccines (915)
Venture capital (95)
Weight loss (395)
Women's health (69)
Worklife (21)
Date
Today (28)
Last 7 days (611)
Last 30 days (2353)
Last 365 days (30023)
2026 (2864)
2025 (30346)
2024 (35514)
2023 (40247)
2022 (50369)
2021 (53519)
2020 (50519)
2019 (41710)
2018 (31895)
2017 (32336)
2016 (30457)
2015 (35846)
2014 (28506)
2013 (23511)
2012 (25083)
2011 (25262)
2010 (23127)
Location
Africa (679)
Alabama (91)
Alaska (6)
Arizona (224)
Arkansas (11)
Asia (41178)
Australia (6716)
California (11213)
Canada (3202)
China (1123)
Colorado (466)
Connecticut (476)
Delaware (311)
Europe (90342)
Florida (1626)
Georgia (342)
Hawaii (4)
Idaho (58)
Illinois (744)
India (67)
Indiana (529)
Iowa (23)
Japan (390)
Kansas (120)
Kentucky (38)
Louisiana (24)
Maine (76)
Maryland (1206)
Massachusetts (8256)
Michigan (328)
Minnesota (630)
Mississippi (4)
Missouri (126)
Montana (33)
Nebraska (25)
Nevada (120)
New Hampshire (82)
New Jersey (2966)
New Mexico (31)
New York (2879)
North Carolina (1522)
North Dakota (8)
Northern California (5474)
Ohio (307)
Oklahoma (18)
Oregon (47)
Pennsylvania (2207)
Puerto Rico (22)
Rhode Island (47)
South America (1067)
South Carolina (64)
South Dakota (1)
Southern California (4266)
Tennessee (141)
Texas (1690)
United States (39344)
Utah (320)
Vermont (1)
Virginia (254)
Washington D.C. (76)
Washington State (926)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
667,678 Results for "bristol myers squibb company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025
February 5, 2026
·
1 min read
Press Releases
OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers Squibb
February 4, 2026
·
3 min read
Press Releases
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
January 21, 2026
·
4 min read
Press Releases
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
January 20, 2026
·
3 min read
Press Releases
Bristol Myers Squibb Introduces “Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care
February 4, 2026
·
3 min read
Press Releases
Bristol Myers Squibb Announces Dividend Increase - December 10, 2025
December 11, 2025
·
1 min read
Press Releases
Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference
January 5, 2026
·
1 min read
Press Releases
Bristol Myers Squibb to Host Hematology-Focused Investor Event
November 24, 2025
·
1 min read
Press Releases
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
December 18, 2025
·
1 min read
Press Releases
Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference
November 27, 2025
·
1 min read
1 of 66,768
Next
